Fortune International Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹0.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.00 per cent from ₹0.00 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Operating Profit
Operating Profit stands at ₹-0.06 crore, reflecting a quarter-on-quarter *(QoQ) increase of 33.33 per cent from ₹-0.09 crore. This corresponds to a year-on-year *(YoY) decline of 200.00 per cent.
PBDT
PBDT stands at ₹1.10 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 37.14 per cent from ₹1.75 crore. This corresponds to a year-on-year *(YoY) decline of 36.42 per cent.
Profit Before Tax
Profit Before Tax stands at ₹1.10 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 37.14 per cent from ₹1.75 crore. This corresponds to a year-on-year *(YoY) decline of 36.42 per cent.
Net Profit
Net Profit stands at ₹1.10 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 37.85 per cent from ₹1.77 crore. This represents a 36.42 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Fortune International Ltd Earnings
- YOY
- QOQ
Fortune International Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Fortune International Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Fortune International Ltd Financial Reports
Fortune International Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Fortune Interntl | 0.93% | 6.82% | -0.30% | 5.65% | 15.76% | 33.99% |
| Aureate Tradde | 0.62% | 0.17% | 37.64% | 33.20% | -27.35% | -27.35% |
| Reganto Enterprises | 3.72% | 12.97% | 3.98% | -39.07% | -45.50% | -80.27% |
| Vivid Mercantile | -0.51% | 0.69% | 0.52% | -7.78% | -22.12% | 1.40% |
| Sunrise Efficie. | 2.77% | 0.27% | -24.11% | -36.89% | -65.99% | -91.25% |
| Panth Infinity | 0.20% | -2.80% | 1.92% | 1.20% | 10.04% | 45.45% |
| Genpharmasec | -5.66% | -9.09% | -11.50% | -7.41% | -11.50% | -43.18% |
Company Info
Company Information
Executive Director & MD : Nivedan Bhardwaj
Executive Director : Rekha Shrivastava
Executive Director : Ruchika Bharadwaj
Independent Director : Sarika Jain
Independent Director : Prashant Verma
Company Sec. & Compli. Officer : Srishti Vig